KLRS Kalaris Therapeutics Net earnings per share growth forecast for next year

KLRS (kalaristx.com) - company brandmark

Kalaris Therapeutics Inc (KLRS) management is currently adapting its portfolio for retinal therapy, creating advance demand for the shares. The GURU.Markets interface displays this chart, where the projected profit dynamics for the company next year reflect a metric value of -7.60. This growth is driven by the recruitment of leading virologists into a flexible R&D environment and the potential of ophthalmological drugs for AMD patients, which are highly sought after by insurance systems.

Kalaris Therapeutics Inc. (KLRS): Earnings growth forecast for next year from 03/20/2025 to 11/18/2026

Comprehensive metric breakdowns and analytics for Kalaris Therapeutics (KLRS)

Basic company analysis:KLRS, Kalaris Therapeutics Inc
Core merchandise of kalaristx.com

This metric reflects the trend of consensus forecasts for year-over-year changes in earnings per share, measuring market expectations regarding future profitability. An upward curve signals a reassessment of the business's fundamental value, which is critical for companies lacking current cash flow. By analyzing the history of earnings per share expectation changes, an investor assesses the success of Kalaris Therapeutics Inc (KLRS) clinical developments as the primary driver of capitalization.

Competitor analysis for Kalaris Therapeutics Inc

Expected earnings per share growth for next year GILD|Earnings growth forecast for next year Cidara Therapeutics, Inc.|Net earnings per share growth forecast for next year Novavax Inc (NVAX)|Consensus forecast of earnings per share growth for next year CureVac|Valneva Pharma - Expected earnings per share growth for next year|Consensus forecast of earnings per share growth for next year Vir Corp (VIR)|siga.com - Earnings growth forecast for next year|Expected net earnings per share growth next year emergentbiosolutions.com|AVIR: Earnings growth forecast for next year|IVVD (Invivyd Inc) - Net earnings per share growth forecast for next year|Net earnings per share growth forecast for next year Enanta Pharmaceuticals|Inovio Pharma (INO) - Consensus forecast of earnings per share growth for next year|Earnings growth forecast for next year HLVX|Consensus forecast of earnings per share growth for next year Dyadic International, Inc.|Earnings growth forecast for next year NNVC (nanoviricides.com)|Talphera Inc (TLPH) - Expected net earnings per share growth next year|COCP: Expected earnings per share growth for next year|Net earnings per share change forecast for next year TRAW|DWTX (Virios Therapeutics) - Expected earnings per share growth for next year|Projected earnings per share growth rate for next year QLGN|ALVR (AlloVir) - Earnings growth forecast for next year|vbivaccines.com (VBIV) - Consensus forecast of earnings per share growth for next year|Earnings growth forecast for next year VIRI|Expected earnings per share growth for next year Vaxart Corp VXRT